U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06961084) titled 'Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer' on April 29.
Brief Summary: Persons diagnosed with thyroid cancer are often treated initially with a thyroidectomy, which is followed by ablation using Iodine-131, a therapy which has been shown to be effective and safe. Imaging of metastatic thyroid cancer has been performed with whole body I-131 and Iodine 123 (I-123) imaging for many decades and use I-123 for staging studies. Iodine 124 (I-124) is a radioisotope of iodine which emits a positron and is imaged using PET (positron emission tomography). This is a single arm prospective trial that evaluates the ability of I...